Cigna to Acquire Express Scripts for $67 Billion
- Drives greater affordability and connectivity with customers and their health care providers, while making health care simpler
- Creates an expanded portfolio of health services with greater choice, alignment and value across a proven services platform
- Expands distribution of health services for employers, health plans and government agencies
- Delivers first year double digit earnings per share accretion and enhances Cigna’s revenue and earnings growth
“Cigna’s acquisition of
“First and foremost, we believe this transaction delivers attractive value to the
Compelling Strategic Benefits
- Expanded Consumer Choice. Offering a full suite of medical, behavioral, specialty pharmacy and other health engagement services accessible across a wide array of retail and online distribution channels, providing optionality for all customers. This will position the combined company to deliver superior services, responding fully to the dynamic needs of our customers and clients, which will drive long-term value creation for shareholders.
- Patient-Provider Alignment. Using a broad and proven network of delivery system partnerships to drive the combined company’s role as the connective tissue between individuals and their health care providers, providing a more coordinated approach to an individual’s health care journey, reducing complexity and creating better outcomes.
- Personalized Value. Making health care simpler for consumers by harnessing actionable insights and predictive analytics, maximizing adoption of evidence-based care and delivering industry-leading innovation and medical technology to support care decisions.
Terms of the Agreement
Under the terms of the definitive agreement, the transaction consideration will consist of
Upon closing, the combined company will be led by
The combined company will be named Cigna. Cigna's headquarters in
Financing, Closing and Approvals
Cigna intends to fund the cash portion of the transaction consideration through a combination of cash on hand, assumed
The transaction, which is expected to be completed by
Advisors
Joint Conference Call
Cigna and
The call-in numbers for the conference call are as follows:
Live Call
(888) 324-757 (Domestic)
(210) 234-0013 (International)
Passcode: 3082018
Replay
(866) 423-4831 (Domestic)
(203) 369-0844 (International)
It is strongly suggested you dial in to the conference call by
For More Information
Information regarding the transaction can also be found on the transaction website.
About Cigna
About
Headquartered in
For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.
FORWARD LOOKING STATEMENTS
Information included or incorporated by reference in this communication, and information which may be contained in other filings with the
Forward-looking statements, including as they relate to
- the inability of
Express Scripts and Cigna to obtain stockholder or regulatory approvals required for the merger or the requirement to accept conditions that could reduce the anticipated benefits of the merger as a condition to obtaining regulatory approvals; - a longer time than anticipated to consummate the proposed merger;
- problems regarding the successful integration of the businesses of
Express Scripts and Cigna; - unexpected costs regarding the proposed merger;
- diversion of management’s attention from ongoing business operations and opportunities;
- potential litigation associated with the proposed merger;
- the ability to retain key personnel;
- the availability of financing;
- effects on the businesses as a result of uncertainty surrounding the proposed merger; and
- the industry may be subject to future risks that are described in
SEC reports filed byExpress Scripts and Cigna.
You should carefully consider these and other relevant factors, including those risk factors in this communication and other risks and uncertainties that affect the businesses of
IMPORTANT INFORMATION ABOUT THE TRANSACTION AND WHERE TO FIND IT
This communication does not constitute an offer to buy or solicitation of an offer to sell any securities. In connection with the proposed transaction, the newly formed company which will become the holding company following the transaction (“Holdco”)” intends to file with the
PARTICIPANTS IN THE SOLICITATION
Cigna (and, in some instances, Holdco) and
NO OFFER OR SOLICITATION
This communication is for informational purposes only and not intended to and does not constitute an offer to subscribe for, buy or sell, the solicitation of an offer to subscribe for, buy or sell or an invitation to subscribe for, buy or sell any securities or the solicitation of any vote or approval in any jurisdiction pursuant to or in connection with the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180308005488/en/
Cigna
Investor Relations
or
Media Relations
or
Investor Relations
or
Media Relations
Source:
“Legislative Review of H.R.5059, the ‘State Insurance Regulation Preservation Act.'”
Collaborative Areas – Wall Installation
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News